InterCure Ltd.
INCR
$1.35
-$0.03-2.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 66.69M | 65.37M | 64.56M | 68.56M | 72.94M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 66.69M | 65.37M | 64.56M | 68.56M | 72.94M |
| Cost of Revenue | 55.40M | 54.12M | 53.18M | 52.47M | 52.05M |
| Gross Profit | 11.29M | 11.25M | 11.38M | 16.09M | 20.89M |
| SG&A Expenses | 28.67M | 29.13M | 29.77M | 27.27M | 24.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 7.41M | 6.34M | 5.21M | 706.40K | -3.79M |
| Total Operating Expenses | 91.59M | 89.70M | 88.28M | 80.55M | 73.24M |
| Operating Income | -24.90M | -24.33M | -23.72M | -11.99M | -301.70K |
| Income Before Tax | -24.61M | -24.09M | -23.57M | -19.91M | -16.41M |
| Income Tax Expenses | -4.46M | -4.19M | -3.92M | -1.25M | 1.43M |
| Earnings from Continuing Operations | -20.15 | -19.90 | -19.65 | -18.66 | -17.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 990.90K | 1.17M | 1.35M | 908.10K | 467.30K |
| Net Income | -19.16M | -18.73M | -18.30M | -17.75M | -17.37M |
| EBIT | -24.90M | -24.33M | -23.72M | -11.99M | -301.70K |
| EBITDA | -21.34M | -21.10M | -20.80M | -9.18M | 2.73M |
| EPS Basic | -0.43 | -0.43 | -0.42 | -0.40 | -0.39 |
| Normalized Basic EPS | -0.40 | -0.39 | -0.38 | -0.22 | -0.07 |
| EPS Diluted | -0.43 | -0.43 | -0.42 | -0.40 | -0.39 |
| Normalized Diluted EPS | -0.40 | -0.39 | -0.38 | -0.22 | -0.07 |
| Average Basic Shares Outstanding | 201.54M | 192.51M | 183.48M | 184.31M | 185.15M |
| Average Diluted Shares Outstanding | 201.54M | 192.51M | 183.48M | 184.31M | 185.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |